Moderna to Seek U.S., EU Clearance for Covid Vaccine

About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

  • Prince Charles Remember’s His ‘Dear Papa’ and Is Grateful’ for World’s Support
  • The Price of Ramadan’s Staple Fruit Is Surging
  • Chad President Facing Growing Resistance in Bid For Sixth Term
  • Bloomberg Quicktake: Now published this video item, entitled “Moderna to Seek U.S., EU Clearance for Covid Vaccine” – below is their description.

    Moderna Inc. plans to request clearance for its coronavirus vaccine in the U.S. and Europe on Monday, after a new analysis showed the vaccine was highly effective in preventing Covid-19, with no serious safety problems.

    The primary analysis, which included 196 cases, found the vaccine was 94.1% effective, in line with preliminary findings released earlier this month. All 30 severe cases observed in the study occurred in participants who received a placebo, according to a company statement, indicating 100% efficacy against severe disease for the shot.

    Moderna shares rose as much as 18% Monday morning in New York to a record $150. They have gained more than sixfold since the year began. The company’s market capitalization of more than $58 billion has surpassed that of Regeneron Pharmaceuticals Inc., which had $7.8 billion in revenue last year and is producing a Covid-19 antibody cocktail.

    The new results put the Cambridge, Massachusetts-based biotechnology company on track to have one of the first Covid-19 vaccines to be cleared in the U.S. A similar vaccine from Pfizer Inc. and BioNTech SE was submitted to U.S. regulators earlier this month and is scheduled to be reviewed ahead of Moderna’s shot.

    Moderna said it plans to apply on Monday for an emergency-use authorization for the vaccine in the U.S. and for conditional marketing authorization in Europe. Advisers to the U.S. Food and Drug Administration will likely scrutinize the data at a public meeting on Dec. 17, the company said, one week after a similar review of Pfizer’s vaccine is expected to take place.

    U.S. regulators declined to confirm the timeline. ”We respectfully decline to comment at this time,” Abigail Capobianco, a spokeswoman for the FDA, said in an email.

    “We have been working nonstop in the last few weeks” to get the vaccine data ready to submit to regulators, Stephane Bancel, Moderna’s chief executive officer, said in an interview. Once authorities sign off, the company will move quickly to distribute the shots, part of a vast vaccination effort that will unfold as hospitals in the U.S. strain under a surge in infections.

    “We are ready today to ship the vaccine,” Bancel said. “We have millions of doses ready, we have more and more every couple days.”

    The U.S. reached a deal worth up to $1.5 billion for 100 million doses of the Moderna shot in August. The European Union, Canada and Japan have also have large purchase agreements, and the U.K. has secured 7 million doses.

    If the vaccine is cleared in the U.S., which Bancel said could occur as soon as 24 to 72 hours after the Dec. 17 meeting, Moderna’s entire inventory will be sent to the federal government. New lots will be shipped as soon as they pass muster, Bancel said. The company expects to be able to ship 20 million doses in the U.S. by the end of the year.

    The new analysis showed the vaccine worked consistently well in older and younger adults, as well as minorities, the company said. Moderna didn’t disclose the vaccine’s exact efficacy in those groups, and Bancel said that more detailed data is still being finalized.

    Overall, there were 185 cases of Covid-19 in trial participants who got a placebo, and 11 cases in people who got the vaccine.

    As mandated by the FDA, Moderna said it had also accumulated two months of safety data from its final-stage trial of more than 30,000 participants. Reported side effects included injection-site pain, fatigue, muscle or joint pain and headache. The side effects were more common and severe after the second dose of the two-dose vaccine, Moderna said.

    The results bolster an interim analysis released on Nov. 16, which showed the vaccine was 94.5% effective in preventing symptomatic Covid-19 and successful in preventing the most severe infections.

    Bloomberg Quicktake: Now YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • How to invest in mRNA vaccines that could revolutionise medicine | Counting the Cost
  • French under-55s given AZ jab to get different second vaccine
  • Macron hails first Pfizer vaccines packaged on French soil
  • Vaccine Eligibility Expands to New Yorkers Ages 16 and Over: De Blasio
  • Cuomo Says Memorial to Be Built in New York to Honor Covid Essential Workers
  • In This Story: Canada

    Canada is a country in the northern part of North America. It extends from the Atlantic to the Pacific and northward into the Arctic Ocean, covering 9.98 million square kilometres (3.85 million square miles), making it the world’s second-largest country by total area.

    Its southern and western border with the United States, stretching 8,891 kilometres (5,525 mi), is the world’s longest bi-national land border. Canada’s capital is Ottawa, and its three largest metropolitan areas are Toronto, Montreal, and Vancouver.

    Various Indigenous peoples inhabited what is now Canada for thousands of years before European colonization. The Canada Act 1982, which severed the vestiges of legal dependence on the British Parliament. Canada is a parliamentary democracy and a constitutional monarchy in the Westminster tradition, with a monarch and a prime minister who serves as the chair of the Cabinet and head of government.

    As a highly developed country, Canada has the seventeenth-highest nominal per-capita income globally as well as the thirteenth-highest ranking in the Human Development Index. Its advanced economy is the tenth-largest in the world, relying chiefly upon its abundant natural resources and well-developed international trade networks.

    2 Recent Items: Canada

  • Should Canada adopt universal basic income?
  • Steve Nash was the NBA’s unlikeliest MVP … then he won another one | The Class of ’96
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • The West Block: April 11, 2021 | Jean Chretien reflects on the life and times of Prince Philip
  • 2 million free face masks distributed in Hong Kong
  • “Harry should be here”: Britons react to news Prince Philip’s grandson to return for funeral
  • Peru, Ecuador set to elect new presidents amid fresh lockdown measures
  • Some California theme parks reopen
  • In This Story: Japan

    Japan is an island country in East Asia located in the northwest Pacific Ocean. Part of the Pacific Ring of Fire, Japan comprises an archipelago of 6,852 islands covering 377,975 square kilometers (145,937 sq mi); the country’s five main islands, from north to south, are Hokkaido, Honshu, Shikoku, Kyushu, and Okinawa. Tokyo is Japan’s capital and largest city.

    Japan is divided into 47 administrative prefectures and eight traditional regions. The Greater Tokyo Area is the most populous metropolitan area in the world, with more than 37.4 million residents.

    Japan is a great power and a member of numerous international organizations, including the United Nations (since 1956), the OECD, and the G7. Japan is a leader in the automotive and electronics industries.

    4 Recent Items: Japan

  • E3 isn’t dead yet
  • IMF Partnerships during the Pandemic: Developing Capacity for a Sustainable Recovery
  • China calls for Japan on wastewater of Fukushima cautiously
  • CBD Boom Spreads to Hong Kong as China Resists
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • How to invest in mRNA vaccines that could revolutionise medicine | Counting the Cost
  • Fmr. FDA Commissioner Scott Gottlieb on global vaccine distribution
  • CDC: 1 in 5 Americans are fully vaccinated
  • French under-55s given AZ jab to get different second vaccine
  • COVID-19: ‘More than enough’ vaccines for under-30s – Hancock
  • Leave a Comment